FDA Reports ‘Proliferation’ Of Cosmetics Making Drug Claims
This article was originally published in The Tan Sheet
Executive Summary
In a Consumer Update posted to its website, FDA suggests some cosmetic products “go too far” with their promises and urges consumers to be skeptical when faced with cosmetics making drug claims.
You may also be interested in...
Cosmeceutical Pioneer Strivectin’s ‘Anti-Aging Solutions’ Draw Drug Claim Warning
FDA cites Strivectin’s Potent Wrinkle Reducing Treatment and TL Advanced Tightening Neck Cream as unapproved drugs based on claims touting elastin-stimulating effects, skin-firming action and other structure/function benefits.
FDA Remains Focused On Cosmetics Carrying Drug Claims – OCAC Director
At the American Conference Institute’s Legal, Regulatory and Compliance Forum on Cosmetics, FDA Office of Cosmetics and Colors Director Linda Katz discussed her division’s priorities for the year. On the enforcement front, OCAC will continue to focus on cosmetic products marketed with drug claims, she said.
ICCS President Hill On Growing Regulatory Confidence In Alternative Testing Methodologies
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they build frameworks for assessing cosmetic safety without animal tests. ICCS president and CEO Erin Hill discusses current challenges and what lies ahead.